Monserrat-Mesquida, M.; Bouzas, C.; Mascaró, C.M.; Tejada, S.; Sureda, A.
Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD). Fermentation 2023, 9, 395.
https://doi.org/10.3390/fermentation9040395
AMA Style
Monserrat-Mesquida M, Bouzas C, Mascaró CM, Tejada S, Sureda A.
Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD). Fermentation. 2023; 9(4):395.
https://doi.org/10.3390/fermentation9040395
Chicago/Turabian Style
Monserrat-Mesquida, Margalida, Cristina Bouzas, Catalina M. Mascaró, Silvia Tejada, and Antoni Sureda.
2023. "Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)" Fermentation 9, no. 4: 395.
https://doi.org/10.3390/fermentation9040395
APA Style
Monserrat-Mesquida, M., Bouzas, C., Mascaró, C. M., Tejada, S., & Sureda, A.
(2023). Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD). Fermentation, 9(4), 395.
https://doi.org/10.3390/fermentation9040395